Patent: 10,646,569
✉ Email this page to a colleague
Summary for Patent: 10,646,569
| Title: | High concentration protein formulations with reduced viscosity |
| Abstract: | The present disclosure, among other things, provides low-viscosity, high concentration therapeutic protein agent formulations. |
| Inventor(s): | Bhami Shenoy |
| Assignee: | Bhami's Research Laboratory Pvt Ltd |
| Application Number: | US15/542,921 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,646,569
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 21-May-04 | ⤷ Start Trial | 2037-06-20 |
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 26-Mar-07 | ⤷ Start Trial | 2037-06-20 |
| Octapharma Pharmazeutika Produktionsges.m.b.h. | OCTAGAM | immune globulin intravenous (human) | Injection | 125062 | 11-Jul-14 | ⤷ Start Trial | 2037-06-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,646,569
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 3063324 | ⤷ Start Trial |
| European Patent Office | 3624846 | ⤷ Start Trial |
| Singapore | 11202003754Y | ⤷ Start Trial |
| United States of America | 11738082 | ⤷ Start Trial |
| United States of America | 2018333493 | ⤷ Start Trial |
| United States of America | 2020254094 | ⤷ Start Trial |
| United States of America | 2024115702 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
